Eagle Pharmaceuticals (EGRX) Revenue

214 Followers

Eagle Pharmaceuticals Revenue

Eagle Pharmaceuticals had a revenue of 64.65M in the quarter ending Jun 30, 2023, with -2.50%. This bring the company's revenue in the last twelve months to 257.55M, Increased -3.55%. In the fiscal year ending Dec 31, 2022, Eagle Pharmaceuticals had annual revenue of 316.61M with 84.56% growth.

Revenue (ttm)

257.55M

Revenue Growth

―

P/S Ratio

0.05

Revenue/Employee

$2,345,259

Employees

135

Market Cap

$16.73M

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2022	316.61M	145.06M	+84.56%
Dec 31, 2021	171.55M	-16.26M	-8.66%
Dec 31, 2020	187.80M	-8.09M	-4.13%
Dec 31, 2019	195.89M	-17.42M	-8.17%
Dec 31, 2018	213.31M	-23.39M	-9.88%
Dec 31, 2017	236.71M	―	―